ArticleActa biomaterialia2025
Extracellular matrix repair and organization of chronic infected diabetic wounds treated with methacrylated chitosan-based hydrogels.
Article in Acta biomaterialia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- AI-assisted design of a VEGFR2 agonistic peptide that promotes angiogenesis and wound repair.Protein science : a publication of the Protein Society · 2026Article
- Applications of Nanomaterials in Chronic Wound Healing and Scar Prevention.International journal of nanomedicine · 2026Review
- Cellular and Molecular Mechanisms of Wound Repair: From Biology to Therapeutic Innovation.Cells · 2025Review
- Investigating the molecular mechanisms of resveratrol in treating diabetic foot ulcers: a comprehensive analysis of network pharmacology and experiment validation.Frontiers in molecular biosciences · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Diabetic foot ulcers (DFUs) are a multifactorial medical problem that require multifaceted approaches for effective healing. Most research on DFU healing has concentrated on promoting wound closure, with less emphasis on the quality of repaired tissue. This is problematic, however, since quality of the repaired tissues can have potential to improve wound healing outcomes and limit re-ulceration. If more functionally active dermis replaces the lost tissue, this can effectively maximize strength, organization, and overall structure of the plantar surface. Additionally, DFUs commonly show multi-strain infection, which further exacerbates the non-healing status of these wounds. Treatment of chronic wounds can be benefitted by application of oxygen and localized infection treatment, both can be achieved via our methacrylated chitosan-based (MACF) hydrogel. A non-healing diabetic infected wound model was used to explore extracellular matrix (ECM) organization, tensile strength, and metabolomic profiles at a 21-day endpoint as a marker for maturation and improved functionality of repaired tissues over normal scar formation. Effective remediation of infection was achieved with 14 days of polyhexamethylene biguanide (PHMB) application with improved wound repair compared to continuous treatment. Prolonged (21 day) application of PHMB showed resulting necrosis, although standard application times for patients with infected wounds can reach up to 28 continuous days. Biaxial mechanical analysis showed improved isotropic strength of infected tissues treated with MACF with PHMB stopped on D14, supported by collagen fiber orientation in second harmonics generation (SHG) imaging. Oxygenating MACF treatments also improved collagen deposition through the enhancement of the hydroxyproline fibrillary collagen synthesis pathway. These structural and mechanical results demonstrate a promising potential treatment for infected diabetic foot ulcers which shows improved dermal functionality. STATEMENT OF SIGNIFICANCE: Diabetic foot ulcers are a multifaceted problem in the medical field exacerbated by infection, with potential for gangrene, lower limb amputation, sepsis, or death. Current treatment regimens include oxygen therapy, physical debridement, and strong antibacterials. However, there is a lack of multi-faceted approaches, which we have designed in our oxygenating chitosan-based hydrogels capable of delivering antibiotics. Treatments currently focus on closure of wounds; however, functionality of regenerated tissues are limited due to fibrotic scar formation. Therefore, we have chosen to focus not only on closure, but also quality of regenerated tissues through mechanical testing and analysis of extracellular matrix composition and organization, with a goal of improving functionality of regenerated tissues.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.